All Stories

  1. Anti-inflammatory effects and safety of omega-3 fatty acids in haemodialysis: A systematic review and meta-analysis
  2. Multi-modal integrated intervention combining exercise, anti-inflammatory, and dietary advice (MMIEAD) for adults with kidney cachexia: protocol for a mixed-methods feasibility cluster randomised controlled trial and process evaluation
  3. Exploring Telomere Association in Donor–Recipient Pairs: Implications for Kidney Graft Longevity
  4. Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes
  5. Variation in Attitudes to Native Kidney Biopsy Practice in the United States
  6. Immune cell subsets in young kidney transplant recipients: Mechanistic and clinical perspectives
  7. Exome-Wide Analysis Identifies a Rare EXD3 Missense Variant Associated With Diabetic Kidney Disease
  8. The Association of Socioeconomic Status on Kidney Transplant Access and Outcomes: Cohort Studies of England and Northern Ireland
  9. Low circulating miR-190a-5p predicts progression of chronic kidney disease
  10. Large Language Models’ Clinical Decision-Making on When to Perform a Kidney Biopsy: Comparative Study
  11. Duke activity status index is not predictive of outcomes after kidney transplantation: a retrospective observational study
  12. Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial
  13. James Frederick Douglas
  14. Genome-Wide Association Study of Quantitative Kidney Function in 52,531 Individuals with Diabetes Identifies Five Diabetes-Specific Loci
  15. Can large language models’ clinical decision-making match human consensus on when to perform a kidney biopsy? (Preprint)
  16. Donor and Recipient Polygenic Risk Scores Influence Kidney Transplant Function
  17. Polygenic risk scores for eGFR are associated with age at kidney failure
  18. Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease
  19. Systematic review of the application of the Kidney Failure Risk Equation and Oxford classification in estimating prognosis in IgA Nephropathy
  20. Non-adherence to immunosuppressive medications in kidney transplant recipients- a systematic scoping review
  21. An International Study of Variation in Attitudes to Kidney Biopsy Practice
  22. The lived experience of renal cachexia: An interpretive phenomenological analysis
  23. Blood methylation biomarkers are associated with diabetic kidney disease progression in type 1 diabetes
  24. Systematic review of the application of the Kidney Failure Equation and Oxford classification in estimating prognosis in IgA Nephropathy
  25. A Novel Role for FERM Domain-Containing Protein 3 in CKD
  26. Does Live Donor and Preemptive Kidney Transplantation Reduce the Impact of Socioeconomic Deprivation on Graft Outcome?
  27. Nonadherence to Immunosuppressive Medications in Kidney Transplant Recipients: A Systematic Scoping Review
  28. ‘Was my kidney biopsy worth it?’–A qualitative phenomenological study of patient experiences and perceived barriers to kidney biopsy
  29. Mitochondrial related variants associated with cardiovascular traits
  30. Frailty, Multimorbidity, and Polypharmacy
  31. Genetic variants affecting mitochondrial function provide further insights for kidney disease
  32. Donor genetic burden for cerebrovascular risk and kidney transplant outcome
  33. Shared genetic features between lymphoma pathogenesis and oestrogen levels
  34. Protocol for a systematic review of the application of the kidney failure risk equation and Oxford classification in estimating prognosis in IgA nephropathy
  35. Genetic and Epigenetic Associations with Post-Transplant Diabetes Mellitus
  36. Latest advances in frailty in kidney transplantation: A narrative review
  37. Low circulating miR-190a-5p predicts progression of chronic kidney disease.
  38. Striking fear into students’ hearts: Unforeseen consequences of prescribing education
  39. Protocol for a Systematic review of the application of the Kidney Failure Risk Equation and Oxford classification in estimating prognosis in IgA Nephropathy
  40. Proteomic analysis investigating kidney transplantation outcomes- a scoping review
  41. Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
  42. Albuminuria-Related Genetic Biomarkers: Replication and Predictive Evaluation in Individuals with and without Diabetes from the UK Biobank
  43. #3022 REDUCED TUBULAR MIR-190A-5P: A NOVEL BIOMARKER FOR STRATIFICATION OF PATIENTS WITH CHRONIC KIDNEY DISEASE
  44. Differential Methylation of Telomere-Related Genes Is Associated with Kidney Disease in Individuals with Type 1 Diabetes
  45. A genome-wide association study identifies a possible role for cannabinoid signalling in the pathogenesis of diabetic kidney disease
  46. Harnessing Genomic Analysis to Explore the Role of Telomeres in the Pathogenesis and Progression of Diabetic Kidney Disease
  47. Longitudinal Epigenome-Wide Analysis of Kidney Transplant Recipients Pretransplant and Posttransplant
  48. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
  49. Empagliflozin in Patients with Chronic Kidney Disease
  50. Early clinical and economic outcomes of expanded criteria living kidney donors in the United States
  51. Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease
  52. Developing an Evidence and Theory Based Multimodal Integrative Intervention for the Management of Renal Cachexia: A Theory of Change
  53. Mesenchymal stromal cell therapy compared to SGLT2-inhibitors and usual care in treating diabetic kidney disease: A cost-effectiveness analysis
  54. Exploring the lived experience of renal cachexia for individuals with end-stage renal disease and the interrelated experience of their carers: Study protocol
  55. An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial
  56. Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease
  57. Harnessing the Full Potential of Multi-Omic Analyses to Advance the Study and Treatment of Chronic Kidney Disease
  58. Dialysis, Distress, and Difficult Conversations: Living with a Kidney Transplant
  59. Clinical features and predictive biomarkers for bladder cancer in patients with type 2 diabetes presenting with haematuria
  60. Polycystic Kidney Disease
  61. Stroke in Hemodialysis Patients Randomized to Different Intravenous Iron Strategies: A Prespecified Analysis from the PIVOTAL Trial
  62. Experiences of renal healthcare practitioners during the COVID-19 pandemic: a multi-methods approach
  63. 57 th EASD Annual Meeting of the European Association for the Study of Diabetes
  64. Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease
  65. Retinal microvascular parameters are not associated with diabetes in the Northern Ireland Cohort for the Longitudinal Study of Ageing
  66. Association of renal impairment with cognitive dysfunction in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA)
  67. Dietary patterns associated with renal impairment in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA)
  68. Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study
  69. The effects of vitamin E supplementation on malondialdehyde as a biomarker of oxidative stress in haemodialysis patients: a systematic review and meta-analysis
  70. Retinal microvascular parameters are not significantly associated with mild cognitive impairment in the Northern Ireland Cohort for the Longitudinal Study of Ageing
  71. A Critical Review of Multimodal Interventions for Cachexia
  72. A systematic review and participant-level meta-analysis found little association of retinal microvascular caliber with reduced kidney function
  73. Erratum
  74. Investigation of associations between retinal microvascular parameters and albuminuria in UK Biobank: a cross-sectional case-control study
  75. Association of reduced retinal arteriolar tortuosity with depression in older participants from the Northern Ireland Cohort for the Longitudinal Study of Ageing
  76. Variation in retinal microvascular parameters is associated with mild cognitive impairment and Alzheimer’s disease
  77. Nurse-led advance care planning with older people who have end-stage kidney disease: feasibility of a deferred entry randomised controlled trial incorporating an economic evaluation and mixed methods process evaluation (ACReDiT)
  78. Using a generic definition of cachexia in patients with kidney disease receiving haemodialysis: a longitudinal (pilot) study
  79. DNA Methylation Associated With Diabetic Kidney Disease in Blood-Derived DNA
  80. The role of motivational and legal contexts in understanding support for tissue donation across 27 European countries
  81. Prospective payment system and racial/ethnic disparities: a national retrospective observational study in anaemia complication among end-stage renal disease patients in the US
  82. Abstracts
  83. Quality of life in advanced renal disease managed either by haemodialysis or conservative care in older patients
  84. Association of retinal venular tortuosity with impaired renal function in the Northern Ireland Cohort for the Longitudinal Study of Ageing
  85. Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease
  86. The Potential of Albuminuria as a Biomarker of Diabetic Complications
  87. Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients
  88. Understanding the holistic experiences of living with a kidney transplant: an interpretative phenomenological study (protocol)
  89. Utility of Phase Angle to Identify Cachexia and Assess Mortality in End-Stage Renal Disease
  90. Hyperamylasemia Post Living Donor Nephrectomy Does Not Relate to Pain
  91. “Mitochondrial Toolbox” – A Review of Online Resources to Explore Mitochondrial Genomics
  92. Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial
  93. The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review
  94. Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locus
  95. Association of reduced inner retinal thicknesses with chronic kidney disease
  96. Association of soluble ST2 with all-cause and cardiovascular mortality in renal transplant recipients: a single-centre cohort study
  97. Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease
  98. Comparison of methylation patterns generated from genomic and cell-line derived DNA using the Illumina Infinium MethylationEPIC BeadChip array
  99. Serum xanthophyll carotenoids are associated with estimated glomerular filtration rate in an aged cohort
  100. Awareness, Understanding and Treatment Practices when Managing Cachexia in End‐Stage Kidney Disease
  101. Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen
  102. The Challenges of Chromosome Y Analysis and the Implications for Chronic Kidney Disease
  103. Differential methylation as a diagnostic biomarker of rare renal diseases: a systematic review
  104. Genetic renal disorders
  105. Differential Expression of Urinary Exosomal MicroRNAs miR-21-5p and miR-30b-5p in Individuals with Diabetic Kidney Disease
  106. Identifying Malnutrition in End-stage Renal Disease (ESRD) (P12-037-19)
  107. Genetic Susceptibility to Chronic Kidney Disease – Some More Pieces for the Heritability Puzzle
  108. Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection
  109. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
  110. Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis
  111. The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population
  112. Serum amyloid A levels are associated with polymorphic variants in the serum amyloid A 1 and 2 genes
  113. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease
  114. Long-Term Outcomes of Renal Transplant in Recipients With Lower Urinary Tract Dysfunction
  115. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
  116. Mitochondria and Chronic Kidney Disease: A Molecular Update
  117. Genome-wide association study of diabetic kidney disease highlights biology involved in renal basement membrane collagen
  118. Risk prediction for acute kidney injury in acute medical admissions in the UK
  119. Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England
  120. Cardiovascular risk in renal transplant recipients
  121. Advance Care Planning With Patients Who Have End-Stage Kidney Disease: A Systematic Realist Review
  122. Validation of differentially methylated microRNAs identified from an epigenome-wide association study; Sanger and next generation sequencing approaches
  123. Genomic approaches in the search for molecular biomarkers in chronic kidney disease
  124. Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort
  125. Quality of life with conservative care compared with assisted peritoneal dialysis and haemodialysis
  126. Healthcare use, costs and quality of life in patients with end-stage kidney disease receiving conservative management: results from a multi-centre observational study (PACKS)
  127. A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
  128. Dietary patterns and chronic kidney disease: a cross-sectional association in the Irish Nun Eye Study
  129. Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes
  130. Retinal microvascular parameters are not associated with reduced renal function in a study of individuals with type 2 diabetes
  131. Establishing a clinical phenotype for cachexia in end stage kidney disease – study protocol
  132. Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study
  133. Arterial stiffness alone does not explain arteriovenous fistula outcomes
  134. Dietary Patterns and Retinal Vessel Caliber in the Irish Nun Eye Study
  135. Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients
  136. Learning to prescribe intravenous fluids: A scoping review
  137. Estimated Glomerular Filtration Rate is not Associated with Alzheimer’s Disease in a Northern Ireland Cohort
  138. Design and implementation of a custom next generation sequencing panel for selected vitamin D associated genes
  139. Development of next generation sequencing panel for UMOD and association with kidney disease
  140. Clinician views of patient decisional conflict when deciding between dialysis and conservative management: Qualitative findings from the PAlliative Care in chronic Kidney diSease (PACKS) study
  141. High-volume haemofiltration for sepsis in adults
  142. Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3
  143. Distinguishing Between Cachexia, Sarcopenia and Protein Energy Wasting in End-Stage Renal Disease Patients on Dialysis
  144. The Genetic Landscape of Renal Complications in Type 1 Diabetes
  145. A Rare Cause of Myoclonus
  146. Wnt6 regulates epithelial cell differentiation and is dysregulated in renal fibrosis
  147. Analysis of single nucleotide polymorphisms implicate mTOR signalling in the development of new-onset diabetes after transplantation
  148. Orals
  149. Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index
  150. EAPC2016: Abstracts
  151. Correction
  152. Does the co-existence of acute anterior uveitis and chronic back pain prompt primary care physicians to consider a diagnosis of axial spondyloarthritis?
  153. Arterial Stiffness and Arteriovenous Fistula Failure of Maturation
  154. Preoperative radial artery volume flow is predictive of arteriovenous fistula outcomes
  155. A HuGE Review and Meta-Analyses of Genetic Associations in New Onset Diabetes after Kidney Transplantation
  156. Bioinformatic Evaluation of Transcriptional Regulation of WNT Pathway Genes with reference to Diabetic Nephropathy
  157. Ethical reasoning through simulation: a phenomenological analysis of student experience
  158. Quality of Life and Physical Function in Older Patients on Dialysis: A Comparison of Assisted Peritoneal Dialysis with Hemodialysis
  159. Investigating clinical predictors of arteriovenous fistula functional patency in a European cohort
  160. Arteriovenous fistula outcomes in the elderly
  161. Evaluation of the Retinal Vasculature in Hypertension and Chronic Kidney Disease in an Elderly Population of Irish Nuns
  162. Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease
  163. PAlliative Care in chronic Kidney diSease: the PACKS study—quality of life, decision making, costs and impact on carers in people managed without dialysis
  164. Genetic renal abnormalities
  165. Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis
  166. Retinal microvascular network attenuation in Alzheimer's disease
  167. DEFINING CACHEXIA IN A RENAL POPULATION
  168. Genetics of Diabetic Nephropathy: a Long Road of Discovery
  169. Learning fluid prescription skills: why is it so challenging?
  170. Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood-derived DNA from individuals with Type 1 diabetes
  171. Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes
  172. Current tools for prediction of arteriovenous fistula outcomes
  173. Diagnosis and management of hyponatraemia: AGREEing the guidelines
  174. Genetic studies of body mass index yield new insights for obesity biology
  175. New genetic loci link adipose and insulin biology to body fat distribution
  176. Patient survival following arteriovenous fistula formation
  177. Optimizing outcomes in the elderly with end-stage renal disease—live long and prosper
  178. Retinal Vascular Caliber, Iris Color, and Age-Related Macular Degeneration in the Irish Nun Eye Study
  179. Next-generation sequencing of the mitochondrial genome and association with IgA nephropathy in a renal transplant population
  180. SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes
  181. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease
  182. AN APPRAISAL OF END-OF-LIFE CARE IN PERSONS WITH CHRONIC KIDNEY DISEASE DYING IN HOSPITAL WARDS
  183. Genetic and epigenetic factors influencing chronic kidney disease
  184. Factors influencing survival after kidney transplant failure
  185. Genetics and Genomics of Chronic Kidney Disease
  186. Surveillance of Nonmelanoma Skin Cancer Incidence Rates in Kidney Transplant Recipients in Ireland
  187. Preserving Arteriovenous Fistula Outcomes during Surgical Training
  188. β Cell Glucotoxic-Associated Single Nucleotide Polymorphisms in Impaired Glucose Tolerance and New-Onset Diabetes After Transplantation
  189. Treatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab
  190. Genetic and Epigenetic Risk Factors for Diabetic Kidney Disease
  191. Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes
  192. Basic and clinical science posters
  193. Type 1 diabetes and MODY
  194. Using ancestry-informative markers to identify fine structure across 15 populations of European origin
  195. Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?
  196. A genome-wide association study of anorexia nervosa
  197. New onset diabetes after transplantation: unravelling the pathophysiological process
  198. Polycystic Kidney Disease
  199. Glycated Hemoglobin and Risk of Death in Diabetic Patients Treated With Hemodialysis: A Meta-analysis
  200. Estimated Glomerular Filtration Rate Decline as a Predictor of Dialysis in Kidney Transplant Recipients
  201. Genetics of New-Onset Diabetes after Transplantation
  202. DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease
  203. Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the UK National Diabetes Audit
  204. Management of hyperkalaemia
  205. Bioinformatic Resources For Diabetic Nephropathy
  206. Chromosome 2q31.1 Associates with ESRD in Women with Type 1 Diabetes
  207. Caveolin-1 Single Nucleotide Polymorphism in Antineutrophil Cytoplasmic Antibody Associated Vasculitis
  208. Haplotype association analysis of genes within the WNT signalling pathways in diabetic nephropathy
  209. Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit
  210. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes
  211. Comprehensive Investigation of the Caveolin 2 Gene: Resequencing and Association for Kidney Transplant Outcomes
  212. Association Analysis of Dyslipidemia-Related Genes in Diabetic Nephropathy
  213. Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGFβR1
  214. A LITERATURE REVIEW OF END-STAGE RENAL DISEASE AND CACHEXIA: UNDERSTANDING EXPERIENCE TO INFORM EVIDENCE-BASED HEALTHCARE
  215. High-volume haemofiltration for sepsis
  216. TGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation
  217. Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
  218. Association of Donor and Recipient Calcineurin Inhibitor Pharmacogenomic Variation with Long-Term Allograft Survival
  219. Donor ABCB1 Variant Associates with Increased Risk for Kidney Allograft Failure
  220. New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
  221. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis
  222. Association of MYH9/APOL1 with chronic kidney disease in a UK population
  223. Epigenetics
  224. Association Testing of Previously Reported Variants in a Large Case-Control Meta-analysis of Diabetic Nephropathy
  225. SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes
  226. Genetic Examination of SETD7 and SUV39H1/H2 Methyltransferases and the Risk of Diabetes Complications in Patients With Type 1 Diabetes
  227. Association analysis of proopiomelanocortin (POMC) haplotypes in type 1 diabetes in a UK population
  228. Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes
  229. Association Analysis of Canonical Wnt Signalling Genes in Diabetic Nephropathy
  230. ANCA-associated vasculitis is linked to carriage of the Z allele of  1 antitrypsin and its polymers
  231. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
  232. Genetic renal abnormalities
  233. Elevated soluble cellular adhesion molecules are associated with increased mortality in a prospective cohort of renal transplant recipients
  234. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis
  235. Patterns of hospitalisation before and following initiation of haemodialysis: a 5 year single centre study
  236. Association analysis of Notch pathway signalling genes in diabetic nephropathy
  237. Managing diabetic nephropathy
  238. The finding of reduced estimated glomerular filtration rate is associated with increased mortality in a large UK population
  239. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus
  240. Investigation of ACE, ACE2 and AGTR1 genes for association with nephropathy in Type 1 diabetes mellitus
  241. DNA methylation profiling in cell models of diabetic nephropathy
  242. Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial
  243. Advances in the Genetics of Familial Renal Cancer
  244. Association of Caveolin-1 Gene Polymorphism With Kidney Transplant Fibrosis and Allograft Failure
  245. Erythropoietin-Induced Activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK Pathways Promotes Malignant Cell Behavior in a Modified Breast Cancer Cell Line
  246. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer
  247. Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy
  248. A GREM1 Gene Variant Associates with Diabetic Nephropathy
  249. Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus
  250. Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus
  251. Elevated Homocysteine Is a Predictor of All-Cause Mortality in a Prospective Cohort of Renal Transplant Recipients
  252. Evaluation of Five Interleukin Genes for Association with End-Stage Renal Disease in White Europeans
  253. Genetic Polymorphisms in Nitric Oxide Synthase 3 Gene and Implications for Kidney Disease: A Meta-Analysis
  254. A cautionary tale of a man with haemochromatosis, chronic kidney disease and anaemia referred for erythropoietin therapy
  255. Targeted genome-wide investigation identifies novel SNPs associated with diabetic nephropathy
  256. Revascularization versus Medical Therapy for Renal-Artery Stenosis
  257. High-volume haemofiltration for sepsis
  258. A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy
  259. The Impact of Admissions for the Management of End-Stage Renal Disease on Hospital Bed Occupancy
  260. Association of microsatellite markers on chromosomes 6q27 region and 10p15 region with end-stage renal disease in a UK renal transplant population
  261. Replication studies based on findings from a genome-wide DNA microsatellite screen in diabetic nephropathy
  262. The changing pattern of adult primary glomerular disease
  263. Chronic kidney disease and bisphosphonate treatment: are prescribing guidelines unnecessarily restrictive?
  264. Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines
  265. The coronary artery disease SNP, rs4420638, is associated with diabetic nephropathy rather than end-stage renal disease
  266. Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
  267. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system
  268. Elevated Serum Phosphate Predicts Mortality in Renal Transplant Recipients
  269. Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy
  270. Annotated chromosome maps for renal disease
  271. Investigation of DNA polymorphisms in SMAD genes for genetic predisposition to diabetic nephropathy in patients with type 1 diabetes mellitus
  272. HLA antigen frequencies and Wegener's granulomatosis
  273. Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders
  274. Association of Genetic Variants at 3q22 with Nephropathy in Patients with Type 1 Diabetes Mellitus
  275. Early acute kidney injury in Northern Ireland ICUs
  276. Genetics of Diabetic Nephropathy: Are There Clues to the Understanding of Common Kidney Diseases?
  277. The Challenge of Doing What Is Right in Renal Transplantation: Balancing Equity and Utility
  278. The uptake of cervical cancer screening by renal transplant recipients
  279. Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy
  280. No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetes
  281. The evolution of renal transplantation in clinical practice: for better, for worse?
  282. Investigation ofAdducin 2 (beta)DNA polymorphisms in genetic predisposition to diabetic nephropathy in Type 1 diabetes
  283. Heme Oxygenase-1 Gene Promoter Polymorphisms and Outcomes of Clinical Renal Transplantation
  284. Heme Oxygenase 1: Does It Have a Role in Renal Cytoprotection?
  285. Hypokalaemic paralysis precipitated by distal renal tubular acidosis secondary to Sjögren's syndrome
  286. Critiques of Clinical Guidelines in Nephrology: Anaemia
  287. Pathophysiology of anemia and erythrocytosis
  288. Association of functional haem oxygenase-1 gene promoter polymorphism with polycystic kidney disease and IgA nephropathy
  289. The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease
  290. Troponin T is an independent predictor of mortality in renal transplant recipients
  291. Multiple Superoxide Dismutase 1/Splicing Factor Serine Alanine 15 Variants Are Associated With the Development and Progression of Diabetic Nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complication...
  292. Decreased Serum Retinol Is Associated with Increased Mortality in Renal Transplant Recipients
  293. In Reply
  294. Association of VEGF-1499C→T polymorphism with diabetic nephropathy in type 1 diabetes mellitus
  295. Genetic renal abnormalities
  296. Gene discovery in diabetic nephropathy
  297. Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation
  298. Association of Functional Heme Oxygenase-1 Gene Promoter Polymorphism with Renal Transplantation Outcomes
  299. Warning Flags for Erythropoiesis-Stimulating Agents and Cancer-Associated Anemia
  300. Reply Orlistat and renal failure
  301. Common polymorphisms of thePAI1gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes
  302. Resequencing of genes for transforming growth factor β1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy
  303. Impaired Downregulation Following Erythropoietin Receptor Activation in Non-Small Cell Lung Carcinoma
  304. Are gatekeepers to renal services referring patients equitably?
  305. Association between Haptoglobin Gene Variants and Diabetic Nephropathy: Haptoglobin Polymorphism in Nephropathy Susceptibility
  306. Cost Should Be the Principal Determinant of Choice of Erythropoiesis-Stimulating Agent in Chronic Haemodialysis Patients
  307. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
  308. Identifying genes for diabetic nephropathy--current difficulties and future directions
  309. Rapidly progressive renal failure associated with successful pharmacotherapy for obesity
  310. The PAX4 gene variant A1168C is not associated with early onset Type 1 diabetes in a UK population
  311. Cardiac tamponade … a wire too far?
  312. Resequencing of the characterised CTGF gene to identify novel or known variants, and analysis of their association with diabetic nephropathy
  313. A Genome-Wide DNA Microsatellite Association Screen to Identify Chromosomal Regions Harboring Candidate Genes in Diabetic Nephropathy
  314. Induction of Signalling in Non-Erythroid Cells by Pharmacological Levels of Erythropoietin
  315. Late referral for assessment of renal failure
  316. Interleukin 18 promoter polymorphisms are not strongly associated with type I diabetes in a UK population
  317. Cytokine gene polymorphisms in ischaemic heart disease: investigation using family-based tests of association
  318. Role of  -adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy
  319. Association Between Variation in the Actin-Binding Gene Caldesmon and Diabetic Nephropathy in Type 1 Diabetes
  320. Association of intercellular adhesion molecule-1 gene with type 1 diabetes
  321. Is screening for factor V leiden and prothrombin G20210A mutations in renal transplantation worthwhile? results of a large single-center U.K. study1
  322. Dialysis Clinic: Skin Thickness and Subcutaneous Erythropoietin
  323. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
  324. Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis
  325. The IL12B 3′ untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes
  326. EPO's Alter Ego: Erythropoietin Has Multiple Actions
  327. Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure
  328. A nested primer set targeting the cytomegalovirus glycoprotein B gene
  329. Influence of progressive renal dysfunction in chronic heart failure
  330. AINT/ERIC/TACC: An Expanding Family of Proteins with C-terminal Coiled Coil Domains
  331. Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus
  332. Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population
  333. The Influence of Transforming Growth Factor-β1 Gene Polymorphisms on the Severity of Gingival Overgrowth Associated With Concomitant Use of Cyclosporin A and a Calcium Channel Blocker
  334. Characterization and localization of expression of an erythropoietin-induced gene, ERIC-1/TACC3, identified in erythroid precursor cells
  335. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation
  336. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation
  337. Is There an Association Between Angiotensin-Converting Enzyme Gene Variants and Chronic Nonproductive Cough?
  338. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus
  339. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth
  340. The Ferroxidase Activity of Caeruloplasmin Is Reduced in Haemodialysis Patients
  341. Allele resolution of HLA-A using oligonucleotide probes in a two-stage typing strategy
  342. Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients
  343. Erythropoietin production: evidence for multiple oxygen sensing pathways
  344. Regulation of Erythropoietin Gene Expression Depends on Two Different Oxygen-Sensing Mechanisms
  345. Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families
  346. Homocysteine and B-group vitamins in renal transplant patients
  347. MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes
  348. Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control
  349. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis
  350. Plasma Glutathione Peroxidase Activity Is Reduced in Haemodialysis Patients
  351. AN INTERLUEKIN 1B ALLELE, WHICH CORRELATES WITH A HIGH SECRETOR PHENOTYPE, IS ASSOCIATED WITH DIABETIC NEPHROPATHY
  352. Sequence characterisation and expression of homeobox HOX A7 in the multi-potential erythroleukaemic cell line TF-1
  353. National scientific medical meeting 1997 abstracts
  354. Autosomal dominant Alport syndrome linked to the type IV collage  3 and  4 genes (COL4A3 and COL4A4)
  355. Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis
  356. Up-regulation of the granulocyte adhesion molecule Mac-1 by autoantibodies in autoimmune vasculitis
  357. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM
  358. A Molecular Variant of Angiotensinogen Is Associated With Diabetic Nephropathy in IDDM
  359. Production and Isolation of the Recombinant N-Lobe of Human Serum Transferrin from the Methylotrophic YeastPichia pastoris
  360. LOCALIZATION OF ERYTHROPOIETIN GENE EXPRESSION IN PROXIMAL RENAL TUBULAR CELLS DETECTED BY DIGOXIGENIN‐LABELLED OLIGONUCLEOTIDE PROBES
  361. LOCALIZATION OF ERYTHROPOIETIN GENE EXPRESSION IN PROXIMAL RENAL TUBULAR CELLS DETECTED BY DIGOXIGENIN-LABELLED OLIGONUCLEOTIDE PROBES
  362. Irish nephrological society
  363. Cytosolic phospholipase A2gene expression in rat mesangial cells is regulated post-transcriptionally
  364. ACE gene typing
  365. Isolation of promoter for cytosolic phospholipase A2 (cPLA2)
  366. Reduced Phospholipase A2 Activity Is Not Accompanied by Reduced Arachidonic Acid Release
  367. Epidermal growth factor and phorbol myristate acetate increase expression of the mRNA for cytosolic phospholipase A2in glomerular mesangial cells
  368. Renal replacement therapy in multiple myeloma and systemic amyloidosis
  369. MicroCorrespondence
  370. Glomerulonephritis associated with antibodies to neutrophil cytoplasm and glomerular basement membrane.
  371. HLA antigen frequencies and Wegener's granulomatosis
  372. Outcome of pregnancy following renal transplantation
  373. Erythropoietin production in kidney tubular cells
  374. Subcutaneous Erythropoietin Therapy and Hypertensive Encephalopathy
  375. The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice
  376. Reversal of renal failure in nephritis associated with antibody to glomerular basement membrane.
  377. Assessment of cell‐mediated immunity in a British population using multiple skin test antigens